WADE SMITH, University of California, San Francisco REFERENCE: Abstract No. LB5 Mechanical removal of the clot that’s causing an acute stroke is showing promising early signs, and is safe. The f
WADE SMITH, University of California, San Francisco
REFERENCE: Abstract No. LB5Mechanical removal of the clot that’s causing an acute stroke is showing promising early signs, and is safe. The first of a new generation of the MERCI (Mechanical Embolus Removal in Cerebral Ischemia) devices for removing clots has compared favorably to its predecessors and can also be used in patients for whom the standard therapy, thrombolysis, has failed.Wade Smithon behalf of the MERCI investigators talked to Helen Morant about the results.
Related Episodes
Routine Angioplasty Recommended After Thrombolysis
Warren Cantor Tony Gershlick REFERENCE: Abstract 2404-3 SCAI-ACCi2 Late-Breaking Clinical Trials II: Acute Myocardial Infarction Warren Cantor, University of Toronto COMMENT: Tony Gershlick, Leicester
Large Risk Reduction For Rivaroxaban In Blood Clot Prevention
Bengt Eriksson REFERENCE: Abstract 6, American Society of Hematology Annual Meeting, December 8-11 2007, Atlanta BENGT ERIKSSON, Gothenburg University In a large phase III trial of patients having a h
GIST Trial: Treating Glucose Levels Acutely Doesn’t Help Survival, but Does Cause Hypotension
CHRISTOPHER GRAY, University of Newcastle REFERENCE: Abstract No. LB2 Treating high blood sugar in the acute phases of stroke doesn’t reduce risk of death or severe disability, the GIST –